Contract facts
FederalNo full NAICS 325412 intel page yet. Browse NAICS intelligence
Nuclear Medicine Radiopharmaceuticals - Year 4 Delivery Order is a federal award for 250-Network Contract Office 10 (36C250) held by Jubilant Draximage Radiopharmacies Inc. Estimated value $310K ($310K obligated). Current period of performance ends Apr 26, 2027. Place of performance: NORCROSS GA.
Nuclear medicine radiopharmaceuticals - year 4 delivery order
Recompete timing
PublicCurrent PoP ends Apr 26, 2027 (191 days remaining). Agencies typically plan 12–18 months ahead — at 6.3 months out, that window is already open. The buying decision is likely already in motion.
Want the durability read on 36C25026N0520? One Pursuit Analysis, $500, inside 48 business hours.
- 48 business hours
- $500
- Credits toward the Pack
Incumbent footprint
Public recordJubilant Draximage Radiopharmacies Inc — $14.3M obligated across 85 awards (firm-wide, all agencies) · lead buyer Department of Veterans Affairs (VA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C25026N0520?
36C25026N0520 (Nuclear medicine radiopharmaceuticals - year 4) is a 250-Network Contract Office 10 (36C250) award with a potential value of $310K, currently held by Jubilant Draximage Radiopharmacies Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is 36C250-26-N-0520?
36C250-26-N-0520 is the dashed form of PIID 36C25026N0520 (Nuclear medicine radiopharmaceuticals - year 4), held by Jubilant Draximage Radiopharmacies Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded 36C25026N0520?
250-Network Contract Office 10 (36C250) awarded 36C25026N0520 to Jubilant Draximage Radiopharmacies Inc (potential $310K).
Who is the incumbent on 36C25026N0520?
Jubilant Draximage Radiopharmacies Inc is the incumbent with $14.3M across 85 related awards in SCOUT’s public footprint. The current period of performance ends Apr 26, 2027.
When does Jubilant Draximage Radiopharmacies Inc’s 36C25026N0520 come up for recompete?
SCOUT tracks a period-of-performance end of Apr 26, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Want the durability read on 36C25026N0520? One Pursuit Analysis, $500, inside 48 business hours.
One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.
No card · under a minute · then the Sprint menu
Use SCOUT in your AI client — $29/moClassify + search inside Claude, ChatGPT, Cursor
Compare plansData: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.